8-K: Chegg Faces NYSE Delisting Warning Over Share Price

Chegg, Inc. received a notice from the NYSE indicating non-compliance with minimum share price requirements, triggering a six-month cure period.

Summary

• Chegg, Inc. has been notified by the New York Stock Exchange (NYSE) that it is not in compliance with the continued listing standard requiring an average closing share price of at least $1.00 over a consecutive 30 trading-day period.
• The period in question ended on July 23, 2026, with the average closing share price falling below $1.00.
• This is a separate issue from a previous notice received in December 2025, which Chegg had cured by the end of May 2026.
• Chegg has a six-month period to regain compliance, during which its stock will continue to be listed on the NYSE.
• To regain compliance, the company may consider options such as a reverse stock split, subject to board approval.
• Compliance can be achieved if, on the last trading day of any month during the cure period, the closing share price is at least $1.00 and the 30-day average closing price is also at least $1.00.
• Failure to regain compliance could lead to suspension and delisting procedures by the NYSE.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative development due to the repeated non-compliance with NYSE listing standards, increasing the risk of delisting and signaling significant investor concern.

Positives

• The notice has no immediate impact on the listing of Chegg's common stock.
• Chegg has a six-month cure period to regain compliance with the minimum share price requirement.
• The company has a history of successfully curing previous listing standard deficiencies.
• Chegg is actively monitoring its share price and evaluating options to regain compliance.

Negatives

• Chegg's average closing share price has fallen below $1.00 for a consecutive 30 trading-day period.
• The company is at risk of suspension and delisting if it fails to regain compliance within the six-month period.
• The need to consider a reverse stock split suggests significant share price underperformance.

Risks

• The possibility that Chegg is unable to regain compliance with the NYSE minimum share price requirement within the six-month cure period.
• The possibility that the NYSE may delist Chegg's common stock.
• Potential negative reactions from employees, vendors, customers, and investors to the notice of non-compliance.
• The risk that Chegg may not be able to continue to comply with other applicable NYSE continued listing standards.
• New risks may emerge that cannot be predicted, potentially impacting the company's ability to meet listing requirements.

Future Outlook

Chegg intends to monitor its stock price and evaluate options to regain compliance with the NYSE minimum share price requirement within the six-month cure period. This may include a reverse stock split, subject to board approval. The company aims to continue trading on the NYSE.

Management Comments

• Chegg is committed to its mission of improving learning outcomes and career opportunities for millions around the world.
• Chegg is a publicly held company and trades on the NYSE under the symbol CHGG.

Industry Context

StockSavvy.ai notes that receiving a NYSE minimum bid price deficiency notice is a significant concern for publicly traded companies, often signaling underlying business challenges or market sentiment. While Chegg has a cure period, the recurrence of this issue suggests persistent headwinds in its stock performance, which is critical for maintaining investor confidence and access to capital markets.

Stakeholder Impact

• Shareholders: Potential for share price volatility and the risk of delisting, which could reduce liquidity and market value.
• Employees: Uncertainty regarding the company's stability and future prospects.
• Customers: Potential concerns about the long-term viability of the company and its services.
• Creditors: Increased risk perception due to potential delisting and financial instability.

Next Steps

• Notify the NYSE of the intent to regain compliance.
• Monitor the closing share price of common stock throughout the cure period.
• Evaluate available options to resolve the deficiency, including a potential reverse stock split.
• Regain compliance with the minimum share price requirement within the six-month period.

Key Dates

Recommendation

While the repeated NYSE minimum bid price deficiency is a significant negative, the company has a six-month cure period and has previously regained compliance. The potential for a reverse stock split offers a path to resolution. However, the underlying reasons for the sustained low share price need to be addressed for a stronger recommendation. A 'hold' reflects the balance between immediate risk and the possibility of recovery.

Keywords

NYSE delisting, minimum share price, continued listing standards, reverse stock split, stock compliance, trading period, cure period, share price